Why IDP Education shares are going gangbusters at a new record high

IDP Education Ltd (ASX: IEL): Buy, hold, sell?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The IDP Education Ltd (ASX: IEL) share price printed a new record high of $15.45 today as it remains one of the best-performing shares on the S&P/ ASX200 (ASX: XJO) over the last couple of years.

It hit the ASX boards in November 2015 at just $2.65 per share to mean it's up 5.8x thanks to some strong revenue, profit, and dividend growth as a public business.

I must admit to being wrong so far in my sense that it's not an investment grade business based largely on the business model of earning fees from repeat English language or IELTS testing that makes up near to 60% of its revenue stream currently.

A lot of its success is based on volume growth in the IELTs testing space, with bulls claiming the tailwind of ever more students requiring English language skills could support the business long into the future.

On top of the profit growth the company has also enjoyed an earnings multiple re-rating as positive sentiment around the business peaks with it now trading on 47x annualised adjusted earnings per share of 33 cents (adjusted half year EPS came in at 16.6 cents).

It has also paid 18.5 cents per share in dividends over the past year to place it on a trailing yield of 1.2%.

According to the Wall Street Journal analysts have a median share price target of $14.35 on IDP shares, with a high estimate of $16. Four out of the eight analysts polled are sitting on the fence with a 'hold' rating, while 2 rate it a 'buy' versus 'one' sell rating.

Personally, I'm more than happy to sit out IDP Education's rise and definitely would not be tempted to buy shares at these kind of elevated valuations usually reserved for hot technology or software businesses.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »